GLP-1 Weight Loss in 2 Weeks: What Actually Happens

Quick Answer

In the first two weeks on GLP-1, weight loss is typically modest — 1 to 5 lbs for most people. The starting dose (0.25 mg for semaglutide) is intentionally low to minimize side effects, which limits the appetite-suppressing effect. More importantly, significant biological changes are already underway even when the scale hasn't moved much.

Why Week 1–2 Is the Starting Dose Phase

GLP-1 medications use a titration schedule — doses start low and increase every 4 weeks. This is not because the medication needs to "build up" (semaglutide reaches steady state within 4–5 weeks at any dose), but because the side effects — particularly nausea — are dose-dependent and need to be introduced gradually.

Semaglutide (Wegovy) titration schedule:

Weeks 1–4: 0.25 mg
Weeks 5–8: 0.5 mg
Weeks 9–12: 1.0 mg
Weeks 13–16: 1.7 mg
Week 17+: 2.4 mg (maintenance)

At 0.25 mg, the appetite effect is present but partial. You're getting perhaps 30–40% of the full hunger-suppressing effect you'll eventually experience.

Tirzepatide (Zepbound) starts at 2.5 mg, titrating up every 4 weeks to a maximum of 15 mg.

Typical Weight Loss at 2 Weeks

Based on the STEP 1 trial week-by-week data and real-world reports:

Average weight loss at 2 weeks: 1–4 lbs
Some patients lose 5–8 lbs (often early water weight and reduced bloating)
Some patients lose nothing visible in week 1–2 (particularly if nausea suppresses the desire to eat but is counterbalanced by other factors)

This range is normal. The 2-week mark is not a good predictor of long-term results.

What IS Changing in the First 2 Weeks

Even when the scale moves slowly, important physiological changes are occurring:

Gastric emptying has already slowed. You may notice you feel fuller sooner at meals and stay satisfied longer. This is the gut mechanism activating.

Hypothalamic signaling has shifted. Most patients notice some degree of food noise reduction — less constant thinking about food — within the first 1–2 weeks.

Blood glucose is improving. For patients with diabetes or prediabetes, GLP-1's insulin-stimulating effects begin immediately. Fasting blood glucose typically drops noticeably within week 1.

Nausea may be peaking. The most common side effect usually peaks in weeks 2–4 at the starting dose, then diminishes as the gut adapts.

Why Some People Experience More Early Loss

Patients who lose more than average in weeks 1–2 often have one or more of these factors:

Significantly reduced appetite from the start
Reduced bloating and water retention (a common early effect)
Higher starting caloric intake, meaning appetite reduction creates a larger immediate deficit
Starting with exercise alongside medication

What to Focus On in Weeks 1–2

Rather than focusing on the scale at 2 weeks, these are more meaningful markers:

Are you experiencing any appetite reduction? Even partial is a good sign.
Are side effects manageable? If nausea is severe, contact your provider — dose adjustment or anti-nausea medication may help.
Are you staying hydrated? Nausea and reduced appetite can reduce water intake; aim for 2+ liters daily.
Are you eating protein? Starting protein-adequate eating habits early helps preserve muscle during eventual weight loss.

Get Started on GLP-1 Today

Bottom Line

Two weeks is too early to judge GLP-1 results. At the starting dose, you're experiencing a fraction of the medication's eventual effect. What matters at week 2 is tolerability and early signs of appetite change — not the number on the scale.